Reported Earlier, BrightSpring Holders Selling Stockholders Price 15M-Share Sale at $58.75 Each
BrightSpring Health Services Announces Secondary Offering Of 15M Shares; Authorizes Concurrent Share Repurchase Of Up To $60M
Morgan Stanley Maintains Overweight on BrightSpring Health, Raises Price Target to $71
A Look At BrightSpring Health Services (BTSG) Valuation As Earnings Upgrades And Buy Ratings Build Momentum
Are Medical Stocks Lagging BrightSpring Health Services, Inc. (BTSG) This Year?
BrightSpring Health Services (BTSG) Is Up 10.3% After Raising 2026 Revenue Guidance And Q1 Beat – Has The Bull Case Changed?
BrightSpring Beat And Guidance Raise Put Valuation And Debt In Focus
Zacks.com featured highlights include BrightSpring Health Services, StoneX and Vista
BrightSpring Health Services, Inc. (BTSG) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Morgan Stanley Maintains Overweight on BrightSpring Health, Raises Price Target to $62
Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $61
TD Cowen Maintains Buy on BrightSpring Health, Raises Price Target to $65
5 Stocks With Recent Price Strength to Gain From April Rally
BrightSpring Health Analysts Increase Their Forecasts Following Q1 Results
Keybanc Maintains Overweight on BrightSpring Health, Raises Price Target to $60
Stephens & Co. Maintains Overweight on BrightSpring Health, Raises Price Target to $64
BMO Capital Maintains Outperform on BrightSpring Health, Raises Price Target to $60
BTIG Maintains Buy on BrightSpring Health, Raises Price Target to $65
BTSG Q1 Deep Dive: Specialty and Infusion Growth Drives Margin Expansion and Upbeat Guidance
BrightSpring Health Services (BTSG) Stock Trades Up, Here Is Why
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.